The Commonwealth is developing a claims scheme to reimburse people who suffer a moderate to significant impact following an adverse reaction to an approved COVID-19 vaccine. It will offer protection to Australians receiving a TGA approved COVID-19 vaccine, irrespective of where that vaccination occurs. It will also ensure that health professionals administering vaccines will be able to continue with their crucial role in the vaccine roll out with assurance that the claims scheme will offer them protection.
The Scheme will be administered by Services Australia and will provide Australians with a single front door to a simple and quick administrative process for compensation. The TGA will provide guidance on recognised adverse reactions as part of their established surveillance program.
The COVID-19 Vaccine Rollout Scheme will be backdated to February 2021 and the registration page will go live on 6 September.
The Scheme will be administered by Services Australia and will provide Australians with a single front door to a simple and quick administrative process for compensation. The TGA will provide guidance on recognised adverse reactions as part of their established surveillance program.
The COVID-19 Vaccine Rollout Scheme will be backdated to February 2021 and the registration page will go live on 6 September.